SoftOx Solutions AS (SOFTX.OL)
Oslo · NOK · Healthcare · Biotechnology
NOK 0.1098 (+0.73%) as of
Key statistics
- Market cap
- 297.50M
- EPS (TTM)
- -0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.0490 – 0.1658
- Beta
- 0.79
- Revenue (TTM)
- 13.88M
- Profit margin
- -165.83%
- Volume
- 20.55M
About SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, yeast, spores, and fungi. SoftOx Solutions AS was founded in 2012 and is based in Lysaker, Norway.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Lysaker, Norway
- Employees
- 2
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.